Close Menu

This article has been updated with additional information from Roche's earnings call.

NEW YORK (GenomeWeb) – Roche today reported an 8 percent year-over-year increase in revenues for its Diagnostics division for the first half of 2018, driven primarily by demand for immunodiagnostic solutions, which are part of the Centralized and Point of Care Solutions business segment.

For the first half of the year, the Roche Group reported CHF 28.11 billion ($28.34 billion) in total sales, up 7 percent from CHF 26.34 billion during the first half of 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.  

Apr
11
Sponsored by
Bionano Genomics

This webinar will review a recent study that applied whole-genome sequencing and optical genome mapping to identify a large number of previously undetected somatic structural variants in leukemia samples.